NUS launches world’s first postgraduate program to integrate geroscience, gerodiagnostics and precision geromedicine into a single curriculum.
The National University of Singapore (NUS) is continuing to build out its healthy longevity offering with a Graduate Certificate in Healthy Longevity Medicine, a semester-long postgraduate program that weaves together geroscience, precision geromedicine and the translational nuts and bolts of practice into a single curriculum.
Built by the NUS Academy for Healthy Longevity at the Yong Loo Lin School of Medicine, the hybrid program starts in August 2026 and is aimed squarely at working professionals – clinicians, researchers, public health people, policymakers, industry leads – who are already busy and intend to stay that way. Two intensive in-person weeks in Singapore bookend several months of online teaching, with the 12-credit certificate deliberately designed as a stepping stone towards a Masters in Healthy Longevity expected to follow in January 2027.
As longevity medicine edges away from being a clever idea on a conference slide and moves closer to everyday clinical work, universities are running up against a more prosaic problem – who, exactly, will be able to read this science, weigh it, and apply it without either overpromising or underusing it?
Longevity.Technology: What feels particularly interesting here is not simply that NUS is putting academic weight behind longevity education – although that matters – but the shape of the curriculum itself. This is not longevity as lifestyle medicine with a few biomarkers sprinkled over the top, nor geroscience kept safely in the laboratory until it has learned to behave itself; it is an attempt to train professionals in the messy middle where biological aging clocks, multi-omics, AI, gerotherapeutics, clinical decision-making, public health and ethics all have to sit at the same table. That matters because precision geromedicine will not be built by enthusiasm alone – perish the thought – but by people who understand both the promise and the limitations of measuring aging, stratifying risk and intervening before pathology has become comfortably established. Singapore’s role here is also worth noting; Asia’s demographic realities make healthy longevity less a speculative frontier and more an operational necessity. The course, then, looks less like another badge to pin on an already crowded lapel and more like an early attempt to say: this is what competence in longevity medicine actually involves. The real test will be whether education can keep pace with the velocity of the science – and whether these credentials harden into shared standards before the market happily sprints past the evidence and starts selling the future by the vial.
Building a longevity curriculum
The program is built around three interconnected courses that try to keep the biological, clinical and societal dimensions of aging in the same shot rather than in separate silos.
The first, Foundations of Healthy Longevity, starts with origin stories – how longevity medicine emerged, how the hallmarks of aging took shape, how life-course epidemiology reframed risk across decades rather than clinic visits. It then pulls in demography and global policy frameworks, so aging is not just cells misbehaving under a microscope but people, systems and time spent in those extra years.
Seen that way, the course is less “biology plus a bit of context” and more an argument that longevity only makes sense when population health, social structures and political choices are part of the conversation. Longer lives are attractive on paper; in practice they drag in questions about who can work, who pays for care, who has support and who is left behind. Those debates, quite rightly, now sit alongside discussions of biomarkers and therapeutics, not as a soft add-on but as part of the brief for what healthy longevity should actually deliver.
It is also a curriculum explicitly designed to split later on; while these initial 12 modular credits serve as the baseline entry point, stackable options will allow students to specialize deeply in either Geroscience or Precision Geromedicine at the full master’s level. By dividing the postgraduate pathway this way, the program acknowledges that while everyone needs the same foundational literacy, the clinician applying an aging clock at the bedside needs a radically different toolkit than the scientist optimizing a drug pipeline in the lab.
The rise of gerodiagnostics
The second component turns to Gerodiagnostics and biomarkers of aging – the part of the field that has spent the last decade trying to turn “getting older” into something you can actually measure.
Participants work across physiological, molecular and digital biomarkers, biological age estimation and aging clocks, and the use of multi-omics and artificial intelligence within precision geromedicine. Woven through that are wearables and digital health technologies, reflecting the quiet but decisive shift from occasional clinic visits to continuous streams of data.
For a field often defined by arguments over which biomarkers matter, and what they really mean, the emphasis here is pointedly translational. Biomarkers are not treated as toys for the lab; the course asks how aging measures might shape clinical judgments and public health decisions in the real world, where patients, payers and regulators all have a view.
Matching interventions to aging biology
The third course moves into Gerointerventions – the “so what” of the curriculum – taking in lifestyle strategies, cognitive and behavioural tuning, environmental levers, nutraceuticals and pharmacological gerotherapeutics.
Rather than parking diagnostics on one side and interventions on the other, it treats the relationship between the two as the main event. Participants look at how multimodal interventions can be stitched to gerodiagnostic findings, working with a precision medicine logic in which aging biology is not background noise but part of how personalised prevention and treatment are decided.
It also walks straight into the regulatory and translational tangle around emerging gerotherapeutics, where promise, hype and uncertainty tend to travel together. That territory is only going to get busier as longevity-focused interventions edge out of tightly controlled experimental settings and begin to ask for space in routine clinical evaluation.
An interdisciplinary audience
Although many longevity programs focus primarily on physicians, NUS has adopted a broader approach. The certificate is open to clinicians, scientists, allied health professionals, public health specialists, policymakers, entrepreneurs and industry leaders.
That diversity mirrors the reality of the field itself. Progress in healthy longevity increasingly depends on collaboration across disciplines that have traditionally operated in relative isolation – laboratory science, clinical practice, digital health, regulation and public policy among them.
To support this, the program places significant emphasis on professional networking, case-based discussion and interaction with faculty, researchers, clinicians and industry participants. The intention appears to be not simply knowledge transfer but community building within an emerging professional domain.
A field finding its shape
For all the noise around longevity science, one problem persists: there simply are not enough people who know how to do it well. Aging clocks, gerotherapeutics and multi-omics platforms will keep iterating; their real value depends on professionals who can see where the evidence is solid, where it is speculative and where, frankly, it is not yet ready for clinic or policy.
As more institutions move to formalize longevity education, programs like this start to sketch out what future training might actually look like – less siloed than traditional medical tracks, but rather more rigorous than the current patchwork of short courses and certificates. The science of aging is still in motion; the educational infrastructure that will decide how, and by whom, it is used is only just beginning to take shape.
The NUS Academy for Healthy Longevity will host an online information session on 5 June 2026 at 7pm Singapore time, providing prospective applicants with an overview of the program structure, curriculum and admissions process – CLICK HERE to register.
READ MORE: Education platform targets longevity knowledge gap
